1
|
Kadi I, Şekerci G, Boulebd H, Zebbiche Z, Tekin S, Benarous K, Serseg T, Küçükbay F, Küçükbay H, Boumoud T. Exploring the anticancer potential of new 3-cyanopyridine derivatives bearing N-acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties. J Biochem Mol Toxicol 2024; 38:e23819. [PMID: 39180345 DOI: 10.1002/jbt.23819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Revised: 07/29/2024] [Accepted: 08/13/2024] [Indexed: 08/26/2024]
Abstract
3-Cyanopyridine derivatives are known for exhibiting excellent anticancer activity due to their strong capability to inhibit various biological targets, including Pim-1 kinase, survivin, and tubulin polymerization. On the other hand, N-acylhydrazones (NAH) are known to be a very versatile motif in medicinal chemistry and drug design. Based on these data, we report in this paper, the synthesis of novel 3-cyanopyridines incorporating N-acyl hydrazine scaffold, the evaluation of their cytotoxicity on the breast (MCF-7) and ovarian (A-2780) cancer cell lines and their antioxidant properties. Excluding 4a and 4d, all tested molecules exhibited high cytotoxicity against A-2780, with IC50 values ranging from 1.14 to 1.76 µM. Conversely, only four molecules 3d, 4b, 4c, and 4d demonstrated cytotoxicity against MCF-7, with IC50 values ranging from 1.14 to 3.38 µM. On the other hand, all the tested molecules exhibited a moderate antioxidant capacity in both the DPPH and metal chelation assays. Docking and molecular dynamics studies revealed that 2d, 3d, and 4d are potential inhibitors of tubulin and the œstrogen receptor, which may explain their high cytotoxicity. These results are promising to study these newly synthesized 3-cyanopyridine-N-acylhydrazones in depth for use as potential anticancer candidates.
Collapse
Affiliation(s)
- Ibtissem Kadi
- Laboratory of Synthesis of Molecules with Biological Interest, University of Constantine 1, Constantine, Algeria
| | - Güldeniz Şekerci
- Physiology Department, Faculty of Medicine, Malatya Turgut Özal University, Malatya, Turkey
| | - Houssem Boulebd
- Laboratory of Synthesis of Molecules with Biological Interest, University of Constantine 1, Constantine, Algeria
| | - Zineddine Zebbiche
- Laboratory of Synthesis of Molecules with Biological Interest, University of Constantine 1, Constantine, Algeria
| | - Suat Tekin
- Physiology Department, Faculty of Medicine, İnönü University, Malatya, Turkey
| | - Khedidja Benarous
- Fundamental Sciences Laboratory, Amar Telidji University, Laghouat, Algeria
| | - Talia Serseg
- Fundamental Sciences Laboratory, Amar Telidji University, Laghouat, Algeria
- Laboratoire des sciences appliquées et didactiques, Ecole Normale Supérieure de Laghouat, Laghouat, Algeria
| | - Fatümetüzzehra Küçükbay
- Basic Pharmaceutical Sciences Department, Faculty of Pharmacy, İnönü University, Malatya, Turkey
| | - Hasan Küçükbay
- Department of Chemistry, Faculty of Arts and Sciences, İnönü University, Malatya, Turkey
| | - Taoues Boumoud
- Laboratory of Synthesis of Molecules with Biological Interest, University of Constantine 1, Constantine, Algeria
| |
Collapse
|
2
|
Kassab AE. N-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years. Curr Pharm Des 2024; 30:333-351. [PMID: 38303528 DOI: 10.2174/0113816128282470240117072322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 12/30/2023] [Accepted: 01/05/2024] [Indexed: 02/03/2024]
Abstract
Due to its important biological and pharmacological properties, in the field of medicinal chemistry and drug discovery, the N-acylhydrazone motif has shown to be extremely adaptable and promising. This scaffold has become a crucial component in the synthesis of numerous bioactive agents. N-Acylhydrazones are also interesting biological and synthetic tools due to their easy and straightforward synthesis. The current review provides a summary of the analgesic and anti-inflammatory activities of N-acylhydrazone derivatives over the past ten years. A brief discussion of structure-activity relationships is also provided which may guide researchers in medicinal chemistry to develop derivatives based on N-acylhydrazone scaffold as potent anti-inflammatory candidates.
Collapse
Affiliation(s)
- Asmaa E Kassab
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt
| |
Collapse
|
3
|
Anjali, Kamboj P, Alam O, Patel H, Ahmad I, Ahmad SS, Amir M. Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors. Arch Pharm (Weinheim) 2024; 357:e2300301. [PMID: 37847883 DOI: 10.1002/ardp.202300301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 09/19/2023] [Accepted: 09/28/2023] [Indexed: 10/19/2023]
Abstract
A new series of quinoxaline derivatives possessing the hydrazone moiety were designed, synthesized, and screened for in-vitro anti-inflammatory activity by the bovine serum albumin (BSA) denaturation technique, and for antioxidant activity, by the (2,2'-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. The synthesized compounds were also tested for p38α mitogen-activated protein (MAP) kinase inhibition. The in-vivo anti-inflammatory activity was assessed by the carrageenan-induced rat paw edema inhibition method. All the compounds (4a-n) exhibited moderate to high in-vitro anti-inflammatory activity. Compound 4a displayed the highest inhibitory activity in the BSA assay (83.42%) in comparison to the standard drug diclofenac sodium (82.90%), while 4d exhibited comparable activity (81.87%). The DPPH assay revealed that compounds 4a and 4d have free radical scavenging potential (74.70% and 74.34%, respectively) comparable to the standard butylated hydroxyanisole (74.09%). Furthermore, the p38α MAP kinase inhibition assay demonstrated that compound 4a is highly selective against p38α MAP kinase (IC50 = 0.042) in comparison to the standard SB203580 (IC50 = 0.044). The five most active compounds (4a-4d and 4f) with good in-vitro profiles were selected for in-vivo anti-inflammatory studies. Compounds 4a and 4d were found to display the highest activity (83.61% and 82.92% inhibition, respectively) in comparison to the standard drug diclofenac sodium (82.65% inhibition). These compounds (4a and 4d) also exhibited better ulcerogenic and lipid peroxidation profiles than diclofenac sodium. The molecular docking and molecular dynamics simulation studies were also performed and found to be in agreement with the p38α MAP kinase inhibitory activity.
Collapse
Affiliation(s)
- Anjali
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Payal Kamboj
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Ozair Alam
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Harun Patel
- Department of Pharmaceutical Chemistry, Division of Computer Aided Drug Design, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, India
| | - Iqrar Ahmad
- Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy, Gondur, Dhule, Maharashtra, India
| | - Syed Sufian Ahmad
- Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Mohd Amir
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| |
Collapse
|
4
|
da Silva PR, Apolinário NDM, da Silva SÂS, Araruna MEC, Costa TB, e Silva YMSDM, da Silva TG, de Moura RO, dos Santos VL. Anti-Inflammatory Activity of N'-(3-(1H-indol-3-yl)benzylidene)-2-cyanoacetohydrazide Derivative via sGC-NO/Cytokine Pathway. Pharmaceuticals (Basel) 2023; 16:1415. [PMID: 37895886 PMCID: PMC10610422 DOI: 10.3390/ph16101415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Revised: 09/13/2023] [Accepted: 09/20/2023] [Indexed: 10/29/2023] Open
Abstract
The N-acylhydrazone function has been reported as a pharmacophore group of molecules with diverse pharmacological activities, including anti-inflammatory effects. Therefore, this study was designed to evaluate the anti-inflammatory potential of the compound N'-(3-(1H-indol-3-yl)benzylidene)-2-cyanoacetohydrazide (JR19) in vivo. The study started with the carrageenan-induced peritonitis model, followed by an investigation of leukocyte migration using the subcutaneous air pouch test and an assessment of the antinociceptive profile using formalin-induced pain. A preliminary molecular docking study focusing on the crystallographic structures of NFκB, iNOS, and sGC was performed to determine the likely mechanism of action. The computational study revealed satisfactory interaction energies with the selected targets, and the same peritonitis model was used to validate the involvement of the nitric oxide pathway and cytokine expression in the peritoneal exudate of mice pretreated with L-NAME or methylene blue. In the peritonitis assay, JR19 (10 and 20 mg/kg) reduced leukocyte migration by 59% and 52%, respectively, compared to the vehicle group, with the 10 mg/kg dose used in subsequent assays. In the subcutaneous air pouch assay, the reduction in cell migration was 66%, and the response to intraplantar formalin was reduced by 39%, particularly during the inflammatory phase, suggesting that the compound lacks central analgesic activity. In addition, a reversal of the anti-inflammatory effect was observed in mice pretreated with L-NAME or methylene blue, indicating the involvement of iNOS and sGC in the anti-inflammatory response of JR19. The compound effectively and significantly decreased the levels of IL-6, TNF-α, IL-17, and IFN-γ, and this effect was reversed in animals pretreated with L-NAME, supporting a NO-dependent anti-inflammatory effect. In contrast, pretreatment with methylene blue only reversed the reduction in TNF-α levels. Therefore, these results demonstrate the pharmacological potential of the novel N-acylhydrazone derivative, which acts through the nitric oxide pathway and cytokine signaling, making it a strong candidate as an anti-inflammatory and immunomodulatory agent.
Collapse
Affiliation(s)
- Pablo Rayff da Silva
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Nadjaele de Melo Apolinário
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Simone Ângela Soares da Silva
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Maria Elaine Cristina Araruna
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Thássia Borges Costa
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Yvnni M. S. de Medeiros e Silva
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Teresinha Gonçalves da Silva
- Departamento de Antibióticos, Centro de Biociências, Universidade Federal de Pernambuco, Recife 50740-520, PE, Brazil;
| | - Ricardo Olímpio de Moura
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| | - Vanda Lucia dos Santos
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil; (P.R.d.S.); (N.d.M.A.); (S.Â.S.d.S.); (M.E.C.A.); (T.B.C.); (Y.M.S.d.M.e.S.); (V.L.d.S.)
- Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil
| |
Collapse
|
5
|
Mikus J, Świątek P, Przybyła P, Krzyżak E, Marciniak A, Kotynia A, Redzicka A, Wiatrak B, Jawień P, Gębarowski T, Szczukowski Ł. Synthesis, Biological, Spectroscopic and Computational Investigations of Novel N-Acylhydrazone Derivatives of Pyrrolo[3,4- d]pyridazinone as Dual COX/LOX Inhibitors. Molecules 2023; 28:5479. [PMID: 37513351 PMCID: PMC10383271 DOI: 10.3390/molecules28145479] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Revised: 07/06/2023] [Accepted: 07/14/2023] [Indexed: 07/30/2023] Open
Abstract
Secure and efficient treatment of diverse pain and inflammatory disorders is continually challenging. Although NSAIDs and other painkillers are well-known and commonly available, they are sometimes insufficient and can cause dangerous adverse effects. As yet reported, derivatives of pyrrolo[3,4-d]pyridazinone are potent COX-2 inhibitors with a COX-2/COX-1 selectivity index better than meloxicam. Considering that N-acylhydrazone (NAH) moiety is a privileged structure occurring in many promising drug candidates, we decided to introduce this pharmacophore into new series of pyrrolo[3,4-d]pyridazinone derivatives. The current paper presents the synthesis and in vitro, spectroscopic, and in silico studies evaluating the biological and physicochemical properties of NAH derivatives of pyrrolo[3,4-d]pyridazinone. Novel compounds 5a-c-7a-c were received with high purity and good yields and did not show cytotoxicity in the MTT assay. Their COX-1, COX-2, and 15-LOX inhibitory activities were estimated using enzymatic tests and molecular docking studies. The title N-acylhydrazones appeared to be promising dual COX/LOX inhibitors. Moreover, spectroscopic and computational methods revealed that new compounds form stable complexes with the most abundant plasma proteins-AAG and HSA, but do not destabilize their secondary structure. Additionally, predicted pharmacokinetic and drug-likeness properties of investigated molecules suggest their potentially good membrane permeability and satisfactory bioavailability.
Collapse
Affiliation(s)
- Jakub Mikus
- Student Science Club of Medicinal Chemistry, Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland; (J.M.); (P.P.)
| | - Piotr Świątek
- Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland;
| | - Patrycja Przybyła
- Student Science Club of Medicinal Chemistry, Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland; (J.M.); (P.P.)
| | - Edward Krzyżak
- Department of Basic Chemical Sciences, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211a, 50-556 Wrocław, Poland; (E.K.); (A.M.); (A.K.)
| | - Aleksandra Marciniak
- Department of Basic Chemical Sciences, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211a, 50-556 Wrocław, Poland; (E.K.); (A.M.); (A.K.)
| | - Aleksadra Kotynia
- Department of Basic Chemical Sciences, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211a, 50-556 Wrocław, Poland; (E.K.); (A.M.); (A.K.)
| | - Aleksandra Redzicka
- Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland;
| | - Benita Wiatrak
- Department of Pharmacology, Faculty of Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 2, 50-345 Wrocław, Poland;
| | - Paulina Jawień
- Department of Biostructure and Animal Physiology, Division of Animal Anatomy, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Kożuchowska 1, 51-631 Wrocław, Poland; (P.J.); (T.G.)
| | - Tomasz Gębarowski
- Department of Biostructure and Animal Physiology, Division of Animal Anatomy, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Kożuchowska 1, 51-631 Wrocław, Poland; (P.J.); (T.G.)
| | - Łukasz Szczukowski
- Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland;
| |
Collapse
|
6
|
El-Miligy MMM, Al-Kubeisi AK, Bekhit MG, El-Zemity SR, Nassra RA, Hazzaa AA. Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors. J Enzyme Inhib Med Chem 2023; 38:294-308. [DOI: 10.1080/14756366.2022.2147164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Affiliation(s)
- Mostafa M. M. El-Miligy
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
| | | | - Mohamed G. Bekhit
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt
| | - Saad R. El-Zemity
- Department of Chemistry and Technology of Pesticides, Faculty of Agriculture, Alexandria University, Alexandria, Egypt
| | - Rasha A. Nassra
- Medical Biochemistry Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
| | - Aly A. Hazzaa
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
| |
Collapse
|
7
|
Acylhydrazones and Their Biological Activity: A Review. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27248719. [PMID: 36557851 PMCID: PMC9783609 DOI: 10.3390/molecules27248719] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 12/02/2022] [Accepted: 12/07/2022] [Indexed: 12/13/2022]
Abstract
Due to the structure of acylhydrazones both by the pharmacophore -CO-NH-N= group and by the different substituents present in the molecules of compounds of this class, various pharmacological activities were reported, including antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory, immunomodulatory, antiedematous, antiglaucomatous, antidiabetic, antioxidant, and actions on the central nervous system and on the cardiovascular system. This fragment is found in the structure of several drugs used in the therapy of some diseases that are at the top of public health problems, like microbial infections and cardiovascular diseases. Moreover, the acylhydrazone moiety is present in the structure of some compounds with possible applications in the treatment of other different pathologies, such as schizophrenia, Parkinson's disease, Alzheimer's disease, and Huntington's disease. Considering these aspects, we consider that a study of the literature data regarding the structural and biological properties of these compounds is useful.
Collapse
|
8
|
Uwagboe I, Adcock IM, Lo Bello F, Caramori G, Mumby S. New drugs under development for COPD. Minerva Med 2022; 113:471-496. [PMID: 35142480 DOI: 10.23736/s0026-4806.22.08024-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The characteristic features of chronic obstructive pulmonary disease (COPD) include inflammation and remodelling of the lower airways and lung parenchyma together with activation of inflammatory and immune processes. Due to the increasing habit of cigarette smoking worldwide COPD prevalence is increasing globally. Current therapies are unable to prevent COPD progression in many patients or target many of its hallmark characteristics which may reflect the lack of adequate biomarkers to detect the heterogeneous clinical and molecular nature of COPD. In this chapter we review recent molecular data that may indicate novel pathways that underpin COPD subphenotypes and indicate potential improvements in the classes of drugs currently used to treat COPD. We also highlight the evidence for new drugs or approaches to treat COPD identified using molecular and other approaches including kinase inhibitors, cytokine- and chemokine-directed biologicals and small molecules, antioxidants and redox signalling pathway inhibitors, inhaled anti-infectious agents and senolytics. It is important to consider the phenotypes/molecular endotypes of COPD patients together with specific outcome measures to target new therapies to particular COPD subtypes. This will require greater understanding of COPD molecular pathologies and a focus on biomarkers of predicting disease subsets and responder/non-responder populations.
Collapse
Affiliation(s)
- Isabel Uwagboe
- Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK
| | - Ian M Adcock
- Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK -
| | - Federica Lo Bello
- Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy
| | - Gaetano Caramori
- Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy
| | - Sharon Mumby
- Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK
| |
Collapse
|
9
|
Mota FVB, Coutinho FN, de Carvalho VMF, de Assis Correia JC, Bastos IVGA, Neto PPM, Ximenes RM, Brondani DJ, de Faria AR, Marchand P, da Silva TG. Antinociceptive Effects of Aza-Bicyclic Isoxazoline-Acylhydrazone Derivatives in Different Models of Nociception in Mice. Curr Top Med Chem 2022; 22:247-258. [PMID: 34986770 DOI: 10.2174/1568026622666220105102508] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 11/18/2021] [Accepted: 11/30/2021] [Indexed: 11/22/2022]
Abstract
BACKGROUND In a study recently published by our research group, the compounds isoxazoline-acylhydrazone derivatives R-99 and R-123 presented promising antinociceptive activity. However, the mechanism of action of this compound is still unknown. OBJECTIVE This study aimed to assess the mechanisms involved in the antinociceptive activity of these compounds in chemical models of pain. METHODS Animals were orally pretreated and evaluated in the acetic acid-, formalin-, capsaicin-, carrageenan- and Complete Freund's Adjuvant (CFA)-induced pain models in mice. The effects of the compounds after pretreatment with naloxone, prazosin, yohimbine, atropine, L-arginine, or glibenclamide were studied, using the acetic acid-induced writhing test to verify the possible involvement of opioid, α1-adrenergic, α2-adrenergic or cholinergic receptors, and nitric oxide or potassium channels pathways, respectively. RESULTS R-99 and R-123 compounds showed significant antinociceptive activity on pain models induced by acetic acid, formalin, and capsaicin. Both compounds decreased the mechanical hyperalgesia induced by carrageenan or CFA in mice. The antinociceptive effects of R-99 and R-123 on the acetic acid-induced writhing test were significantly attenuated by pretreatment with naloxone, yohimbine or atropine. R-99 also showed an attenuated response after pretreatment with atropine and glibenclamide. However, on the pretreatment with prazosin, there was no change in the animals' response to both compounds. CONCLUSION R-99 and R-123 showed antinociceptive effects related to mechanisms that involve, at least in part, interaction with the opioid and adrenergic systems and TRPV1 pathways. The compound R-99 also interacts with the cholinergic pathways and potassium channels.
Collapse
Affiliation(s)
| | - Felipe Neves Coutinho
- Department of Pharmaceutical Sciences, Federal University of Pernambuco (UFPE), Recife-PE, Brazil
| | | | | | | | | | - Rafael Matos Ximenes
- Department of Antibiotics, Federal University of Pernambuco (UFPE), Recife-PE, Brazil
| | - Dalci José Brondani
- Department of Pharmaceutical Sciences, Federal University of Pernambuco (UFPE), Recife-PE, Brazil
| | - Antônio Rodolfo de Faria
- Department of Pharmaceutical Sciences, Federal University of Pernambuco (UFPE), Recife-PE, Brazil
| | - Pascal Marchand
- Département de Chimie Thérapeutique, University of Nantes, 22 Boulevard Bénoni Goullin, France
| | | |
Collapse
|
10
|
de Assis ACL, Moreira LMCDC, Rocha BP, Pereira MRB, de Melo DF, de Moura RO, de Azevedo EP, Oshiro-Junior JA, Damasceno BPGDL. N-acylhydrazone Derivative-Loaded Cellulose Acetate Films: Thermoanalytical, Spectroscopic, Mechanical and Morphological Characterization. Polymers (Basel) 2021; 13:polym13142345. [PMID: 34301102 PMCID: PMC8309645 DOI: 10.3390/polym13142345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 07/12/2021] [Accepted: 07/14/2021] [Indexed: 12/20/2022] Open
Abstract
Cellulose acetate (ACT) is one of the most important cellulose derivatives due to its biodegradability and low toxicity, presenting itself as one of the main substitutes for synthetic materials in the development of wound dressing films. The incorporation of a N-acylhydrazonic derivative (JR19), with its promising anti-inflammatory activity, may represent an alternative for the treatment of skin wounds. This work aims to develop and to physicochemically and mechanically characterize ACT films containing JR19. The films were prepared using the ‘casting’ method and further characterized by thermoanalytical and spectroscopic techniques. In addition, mechanical tests and morphological analysis were performed. Thermogravimetry (TG) and differential scanning calorimetry (DSC) analyses showed that the thermal events attributed to excipients and films were similar, indicating the absence of physical incompatibilities between ACT and JR19. Infrared spectroscopy showed that JR19 was incorporated into ACT films. The characteristic band attributed to C≡N (2279 to 2264 cm−1) was observed in the spectra of JR19, in that of the physical mixture of JR19/ACT, and, to a lesser extent, in the spectra of JR19 incorporated into the ACT film, suggesting some interaction between JR19 and ACT. X-ray diffraction (XRD) evidenced the suppression of the crystallinity of JR19 (diffraction peaks at 8.54°, 12.80°, 14.09°, 16.08°, 18.19°, 22.65°, 23.59°, 24.53°, 25.70°, 28.16° and 30.27°2θ) after incorporation into ACT films. The mechanical tests indicated the adequate integrity of the films and their resistance to bending. The morphological characterization showed JR19 crystals along with a homogeneously distributed porous structure throughout the surface of the films with an average diameter of 21.34 µm and 22.65 µm of the films alone and of those incorporating JR19F, respectively. This study was able to characterize the ACT films incorporating JR19, showing their potential to be further developed as wound healing dressings.
Collapse
Affiliation(s)
- Amaro César Lima de Assis
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Lívia Maria Coelho de Carvalho Moreira
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Beatriz Patrício Rocha
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Milena Raissa Bezerra Pereira
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Demis Ferreira de Melo
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Ricardo Olímpio de Moura
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Eduardo Pereira de Azevedo
- Graduate Program of Biotechnology, Laureate International Universities–Universidade Potiguar (UnP), Natal 59056-000, Rio Grande do Norte, Brazil;
| | - João Augusto Oshiro-Junior
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Correspondence: (J.A.O.-J.); (B.P.G.d.L.D.); Tel.: +55-83-3315-3300 (ext. 3516) (B.P.G.d.L.D.)
| | - Bolívar Ponciano Goulart de Lima Damasceno
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Correspondence: (J.A.O.-J.); (B.P.G.d.L.D.); Tel.: +55-83-3315-3300 (ext. 3516) (B.P.G.d.L.D.)
| |
Collapse
|
11
|
Lo Bello F, Hansbro PM, Donovan C, Coppolino I, Mumby S, Adcock IM, Caramori G. New drugs under development for COPD. Expert Opin Emerg Drugs 2020; 25:419-431. [DOI: 10.1080/14728214.2020.1819982] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Federica Lo Bello
- Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy
| | - Philip M. Hansbro
- Centre for Inflammation, Centenary Institute, Sydney, Australia
- Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia
- Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia
| | - Chantal Donovan
- Centre for Inflammation, Centenary Institute, Sydney, Australia
- Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia
- Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia
| | - Irene Coppolino
- Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy
| | - Sharon Mumby
- Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK
| | - Ian M. Adcock
- Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK
| | - Gaetano Caramori
- Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy
| |
Collapse
|